You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Viral capsid antigen (VCA)

Showing 1 - 25 of 6,365
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

Not yet recruiting
  • Epstein-Barr Virus Infection
  • +2 more
  • Matrix-M1 Adjuvant
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Epstein Barr Virus Infection in Radiologically Isolated Syndrome

Recruiting
  • Multiple Sclerosis
  • +2 more
  • NO INTERVENTION
  • Nice, France
    Nice University Hospital
Apr 3, 2023

Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Tongue image
  • Zhuhai, China
    The Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023

Occurrence of Antibodies Cross-reacting With Autoantigens in

Recruiting
  • Epstein-Barr Virus (EBV) Infection
  • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Nov 8, 2021

Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV antibodies test
  • EBV DNA test
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022

Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility

Completed
  • Nasopharyngeal Carcinoma
    • Beijing, China
      Institute for Viral Disease Control & Prevention
    Jun 15, 2020

    HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

    Not yet recruiting
    • HIV Infections
    • Las Vegas, Nevada
    • +1 more
    Aug 21, 2023

    X-Linked Retinitis Pigmentosa Trial in Meguro-ku (AAV5-hRKp.RPGR)

    Not yet recruiting
    • X-Linked Retinitis Pigmentosa
    • AAV5-hRKp.RPGR
    • Meguro-ku, Japan
      National Hospital Organization Tokyo Medical Center
    Jun 23, 2023

    COVID-19, Influenza A, Influenza Type B Trial in Pelham, Brooklyn (Panbio™ COVID-19/Flu A&B Panel)

    Recruiting
    • COVID-19
    • +2 more
    • Panbio™ COVID-19/Flu A&B Panel
    • Pelham, Alabama
    • +1 more
    Nov 10, 2023

    COPD, Respiratory Disease, Lower Respiratory Disease Trial in Miami (Vapendavir)

    Enrolling by invitation
    • COPD
    • +4 more
    • Miami, Florida
      Syneos Health Miami
    Jul 18, 2023

    Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • AML Stage, Adult
    • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
    • Xiamen, Fujian, China
      Bing Xu
    Oct 29, 2022

    Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

    Recruiting
    • Leukemia, Myeloid, Acute
    • +2 more
    • venetoclax combining chidamide and azacitidine (VCA)
    • Xiamen, Fujian, China
      Bing Xu
    Aug 1, 2022

    EuGeni Rapid Antigen Test for Qualitative Detection of Severe

    Terminated
    • SARS-CoV-2 Infection
    • EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
    • Split, Croatia
    • +4 more
    Jan 3, 2023

    Hemophilia B Trial in Tianjin (Single dose intravenous injection of BBM-H901)

    Active, not recruiting
    • Hemophilia B
    • Single dose intravenous injection of BBM-H901
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 12, 2021

    HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

    Active, not recruiting
    • HIV-1 Infection
    • Oral Lenacapavir
    • +3 more
    • Los Angeles, California
    • +22 more
    Nov 4, 2022

    Methylmalonic Acidemia Trial in United States (hLB-001)

    Recruiting
    • Methylmalonic Acidemia
    • hLB-001
    • Atlanta, Georgia
    • +3 more
    Aug 16, 2022

    Nasopharyngeal Carcinoma Trial (18F-FDG PET/CT, MRI)

    Completed
    • Nasopharyngeal Carcinoma
    • 18F-FDG PET/CT, MRI
    • (no location specified)
    Jun 4, 2020

    HIV Trial in Las Vegas (VH4004280, Placebo)

    Recruiting
    • HIV Infections
    • Las Vegas, Nevada
      GSK Investigational Site
    Jan 6, 2023

    Tricuspid Regurgitation Trial in Boston (Transesophageal echocardiograpgy)

    Recruiting
    • Tricuspid Regurgitation
    • Transesophageal echocardiograpgy
    • Boston, Massachusetts
      Tufts Medical Center
    Jul 11, 2022

    CMV Viremia, CMV Trial in São Paulo (Lymphocyte infusion (ImmuneCellVir-I))

    Recruiting
    • CMV Viremia
    • CMV
    • Lymphocyte infusion (ImmuneCellVir-I)
    • São Paulo, SP, Brazil
      Hospital Israelita Albert Einstein
    Aug 21, 2023

    SARS CoV 2 Infection Trial in Newark (Testing for SARS CoV2 Antigen)

    Completed
    • SARS CoV 2 Infection
    • Testing for SARS CoV2 Antigen
    • Newark, New Jersey
      Rutgers School of Dental Medicine
    Nov 4, 2022

    Amputation, Traumatic, Amputation;Traumatic;Old, Face Injury Trial in Boston (IL-2)

    Terminated
    • Amputation, Traumatic
    • +4 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 22, 2021

    Hemophilia B Trial in Tianjin (ZS801)

    Not yet recruiting
    • Hemophilia B
    • ZS801
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 5, 2022

    SARS-CoV-2 Infection Trial in Liverpool (Innova Lateral Flow Test)

    Completed
    • SARS-CoV-2 Infection
    • Innova Lateral Flow Test
    • Liverpool, United Kingdom
      Alder Hey Children's NHS Foundation Trust
    Nov 9, 2022

    Hemophilia B Trial in Tianjin (ZS801)

    Not yet recruiting
    • Hemophilia B
    • ZS801
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 24, 2022